INTENSITY THERAPEUTICS, INC.
INTS · XNASCIK 1567264fmd_0CCXWHXXZCPW3VQ4SZDDHFKR79Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 18 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Research and development | 5 | 5 | 10 | 7 |
| Total operating expenses | 8 | 8 | 17 | 12 |
| Operating income | (8) | (8) | (17) | (12) |
| Interest expense | 0 | 0 | 0 | – |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | 0 | 0 |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income | (8) | (11) | (16) | (12) |